Biologics will participate in late-stage trial of Neupogen

02/11/2010 | American City Business Journals

The National Marrow Donor Program chose North Carolina's Biologics to oversee inventory and distribution of Neupogen, a drug that boosts white blood cells, during a Phase III trial involving blood stem cell transplant patients with unrelated donors. The trial has been going on since 1997 and is expected to enroll 15,000 participants by 2012.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations